Pages that link to "Q34385057"
Jump to navigation
Jump to search
The following pages link to Serum Globotriaosylceramide Assay as a Screening Test for Fabry Disease in Patients with ESRD on Maintenance Dialysis in Korea (Q34385057):
Displaying 5 items.
- Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma. (Q36691965) (← links)
- A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance (Q38127171) (← links)
- Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis (Q38245997) (← links)
- Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype. (Q38672018) (← links)
- Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease (Q41571017) (← links)